Skip to main navigation Skip to search Skip to main content

Adalimumab (humira) For The Treatment Of Refractory Sight-threatening Non-infectious Uveitis: One Year Outcomes Of An Open-label Prospective Multicenter Study.

  • E Suhler
  • , Careen Lowder
  • , Debra Goldstein
  • , Tracy Giles
  • , Howard Tessler
  • , Andreas Lauer
  • , Justine Smith
  • , J Rosenbaum

    Research output: Contribution to conferencePaperpeer-review

    Original languageEnglish
    Publication statusPublished - 2011
    EventAssociation for Research in Vision and Ophthalmology (ARVO) 2011 -
    Duration: 1 Jan 2011 → …

    Conference

    ConferenceAssociation for Research in Vision and Ophthalmology (ARVO) 2011
    Period1/01/11 → …

    Cite this